MCF-7/Twist

Case ID:
C10075

C10075: Twist overexpression promotes chromosomal instability in the breast cancer cell line MCF-7

Value Proposition:

Chromosomal instability, the continuous formation of novel chromosome mutations at a rate higher than in normal cells, is a defining characteristic of most human cancers. Twist is a basic helix-loop-helix transcription factor that is a major regulator of mesenchymal phenotypes. JHU scientists have developed a breast cancer cell line (MCF-7/Twist) that stably overexpresses human Twist. The overexpression of Twist causes an epithelial to mesenchymal-like transition (EMLT) which leads to an increase in invasiveness and motility of this cell line. Studies of the MCF-7/Twist cell line indicates Twist in some capacity, promotes chromosomal instability in the MCF-7 cell line. These findings have validated previous results that Twist-expressing tumors exhibited increased chromosomal abnormalities as compared to Twist non-expressers. This represents the first direct correlation between overexpression of Twist and increased chromosomal instability in both tissue culture and patient breast tumors.

Looking for Partners:

This cancer cell line can be used as a model to study the role of Twist (a basic-helix-loop-helix protein essential for embryogenesis) in breast cancer biogenesis and metastasis.



Patent Information:
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Vera Sampels
vsampel2@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum